Numbers of patients | 98 |
Male/female ratio | 8/90 |
Median age, years (range) | 58 (21–84) |
Median disease duration, years (range) | 6 (0–26) |
Median T1-T0 interval, months (range) | 12 (4–56) |
lcSSc/dcSSc | 48/50 |
Autoantibodies | |
 ACA, n (%) | 42 (42.8) |
 Anti-Scl-70, n (%) | 50 (51) |
 Others, n (%) | 6 (6.1) |
NVC patterns | |
 Early, n (%) | 16 (16.2) |
 Active, n (%) | 42 (42.8) |
 Late, n (%) | 40 (41) |
Patients on prostanoid therapy, n (%) | 32 (32.6) |